Concepedia

Publication | Open Access

Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma

DOIFull Paper Access

47

Citations

51

References

2015

Year

Heather L. Gardner, Cheryl A. London, Roberta A. Portela, Sandra Nguyen, Mona P. Rosenberg, Mary K. Klein, Craig A. Clifford, Douglas H. Thamm, David M. Vail, Phil Bergman,
BMC Veterinary Research

Abstract

The use of toceranib following DOX chemotherapy does not improve either disease free interval or overall survival in dogs with stage I or II HSA.

References

YearCitations

Page 1